| Q24806707 | A gene expression system offering multiple levels of regulation: the Dual Drug Control (DDC) system |
| Q44326716 | A new colloidal lipidic system for gene therapy |
| Q64379609 | A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent |
| Q45878392 | A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component |
| Q37409025 | Adenoviral vector-based strategies for cancer therapy |
| Q37539305 | Adenovirus with DNA Packaging Gene Mutations Increased Virus Release |
| Q40606271 | Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q33677054 | Advances in preclinical investigation of prostate cancer gene therapy |
| Q40147062 | An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas. |
| Q39673855 | Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro |
| Q39538500 | Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability. |
| Q36288905 | Angiogenic and antiangiogenic gene therapy |
| Q45235059 | Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70. |
| Q35743279 | Approaches to enhance the efficacy of DNA vaccines |
| Q40023775 | Augmented transgene expression in transformed cells using a parvoviral hybrid vector |
| Q39001370 | CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells |
| Q45862174 | Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme |
| Q46945028 | Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury |
| Q37063332 | Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer |
| Q45863319 | Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma |
| Q40782543 | Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo |
| Q43724127 | Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles |
| Q34455157 | Conditional gene targeting for cancer gene therapy |
| Q44420566 | Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon |
| Q48006165 | Dendronized Semiconducting Polymer as Photothermal Nanocarrier for Remote Activation of Gene Expression. |
| Q43747167 | Development of formulations that enhance physical stability of viral vectors for gene therapy. |
| Q36303872 | Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies. |
| Q45883442 | Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12. |
| Q44495042 | Enhanced suicide gene therapy by chimeric tumor-specific promoter based on HSF1 transcriptional regulation |
| Q34233867 | Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain |
| Q40461124 | Evaluation of tumor-specific promoter activities in melanoma. |
| Q45885924 | Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands |
| Q39935539 | Exploiting the tumor microenvironment in the development of targeted cancer gene therapy |
| Q43831004 | Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill. |
| Q40244313 | GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain |
| Q31007035 | GDEP, a new gene differentially expressed in normal prostate and prostate cancer |
| Q35186312 | Gene Therapies for Cancer: Strategies, Challenges and Successes |
| Q34319684 | Gene transfer: manipulating and monitoring function in cells and tissues. |
| Q24806156 | Genetic therapy: on the brink of a new future |
| Q40573309 | Hapten-directed targeting to single-chain antibody receptors |
| Q58772608 | High promoter activity of cytokeratin-19 gene in cholangiocarcinoma |
| Q34340886 | Highly modular bow-tie gene circuits with programmable dynamic behaviour |
| Q30354691 | Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo. |
| Q44007845 | Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter |
| Q39586718 | Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy |
| Q45138390 | Infectious Epstein-Barr virus vectors for episomal gene therapy |
| Q35155806 | Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents |
| Q44364388 | Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. |
| Q35873756 | Light-directed gene delivery by photochemical internalisation |
| Q34676977 | Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects |
| Q50768483 | Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers. |
| Q40746230 | Microencapsulation of genetically engineered cells for cancer therapy |
| Q45884141 | Modification of the hTERT promoter by heat shock elements enhances the efficiency and specificity of cancer targeted gene therapy |
| Q34501927 | Molecular approaches to chemo-radiotherapy. |
| Q33704231 | Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors |
| Q35116121 | Molecular-genetic imaging of cancer |
| Q36729884 | Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals |
| Q35842597 | Nanoparticle-mediated gene delivery: state of the art. |
| Q38327006 | Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. |
| Q35371213 | Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy |
| Q42738940 | Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression |
| Q44168577 | Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. |
| Q36673652 | Nucleic acid therapeutics for hematologic malignancies--theoretical considerations |
| Q40561051 | Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir. |
| Q36484641 | Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy |
| Q25257352 | Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system |
| Q44356546 | Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10. |
| Q34804863 | Prospects for cationic polymers in gene and oligonucleotide therapy against cancer |
| Q36834294 | Respiratory syncytial virus infection: from biology to therapy: a perspective |
| Q43501855 | Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single‐chain diabody (scDb) adapter that binds to fiber knob and HMWMAA |
| Q54112053 | Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro. |
| Q36416427 | Targeted polymeric nanoparticles for cancer gene therapy |
| Q36316688 | Targeted polymers for gene delivery |
| Q43698644 | Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature |
| Q43831003 | Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. |
| Q40386087 | The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context |
| Q39476525 | The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro |
| Q40810330 | The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters |
| Q35570262 | Therapeutic Potential of Antisense Nucleic Acid Molecules |
| Q36394987 | Therapy of cancer by cytokines mediated by gene therapy approach |
| Q35779378 | Tissue-specific promoters for cancer gene therapy |
| Q27013664 | Toxin-based therapeutic approaches |
| Q34079558 | Transcriptional control: an essential component of cancer gene therapy strategies? |
| Q40577044 | Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter |
| Q37459648 | Transcriptional targeting of tumor endothelial cells for gene therapy |
| Q40579096 | Transcriptional targeting of tumors with a novel tumor-specific survivin promoter |
| Q35558678 | Transcriptionally targeted gene therapy to detect and treat cancer |
| Q35184871 | Tumor-specific gene expression using the survivin promoter is further increased by hypoxia |
| Q51115979 | Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model. |
| Q33952065 | Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters |